Dion F. Coakley
Career history of Dion F. Coakley
Former positions of Dion F. Coakley
| Companies | Position | Start | End |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - | - |
| Burroughs Wellcome | Corporate Officer/Principal | - | - |
| HYPERION THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2010-03-24 | - |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 2007-02-28 | - |
Training of Dion F. Coakley
| University of Washington | Doctorate Degree |
| The University of Arkansas | Undergraduate Degree |
Statistics
International
| United States | 6 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
| Burroughs Wellcome | |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
- Stock Market
- Insiders
- Dion F. Coakley
- Experience
